Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis

被引:156
|
作者
Prakash, R. S. [1 ,2 ]
Snook, E. M. [3 ]
Lewis, J. M. [1 ,2 ]
Motl, R. W. [3 ]
Kramer, A. F. [1 ,2 ]
机构
[1] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA
[2] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA
[3] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA
关键词
cognition; disease subtype; meta-analysis; relapsing-remitting multiple sclerosis;
D O I
10.1177/1352458508095004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There is debate in the literature regarding the magnitude, nature, and influence of cognitive impairment in individuals with relapsing-remitting multiple sclerosis (RRMS). Therefore, we conducted a meta-analysis that quantified the overall magnitude of cognitive impairment in individuals with RRMS and identified the domains of cognition and clinical/demographic variables that were moderators of the overall effect. We included 57 studies with 3891 participants that yielded a total of 755 effect sizes. Overall, there was a moderate decline in cognitive functioning in individuals with RRMS compared with healthy controls. Larger effects were observed in cognitive domains of motor functioning, mood status and memory and learning. Regarding demographic and clinical variables, age and gender were moderators of cognitive impairment in all cognitive domains, whereas neurological disability and disease duration primarily moderated performance on tasks assessing memory and learning. Multiple Sclerosis 2008; 14: 1250-1261. http://msj.sagepub.com
引用
收藏
页码:1250 / 1261
页数:12
相关论文
共 50 条
  • [21] Factors associated with relapses in relapsing-remitting multiple sclerosis A systematic review and meta-analysis
    Xie, Yao
    Tian, Ziyu
    Han, Fang
    Liang, Shibing
    Gao, Ying
    Wu, Dahua
    MEDICINE, 2020, 99 (27) : E20885
  • [22] Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
    Lucchetta, Rosa C.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Leonart, Leticia P.
    Ferreira, Vinicius L.
    Bonetti, Aline F.
    Riveros, Bruno S.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    CNS DRUGS, 2018, 32 (09) : 813 - 826
  • [23] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [24] Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis
    Del Santo, Fabiola
    Maratea, Dario
    Fadda, Valeria
    Trippoli, Sabrina
    Messori, Andrea
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (04) : 441 - 448
  • [25] NATALIZUMAB VERSUS GLATIRAMER ACETATE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A NETWORK META-ANALYSIS
    Sultanov, M.
    Almadiyeva, A.
    Absattarova, K.
    Semenova, Y.
    VALUE IN HEALTH, 2018, 21 : S331 - S331
  • [26] SAFETY OUTCOMES IN IMMUNOSUPPRESSANTS AND IMMUNOMODULATORS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS: A NETWORK META-ANALYSIS
    Lucchetta, R. C.
    Leonart, L.
    Pontarolo, R.
    Fernandez-Llimos, F.
    Wiens, A.
    VALUE IN HEALTH, 2019, 22 : S270 - S270
  • [27] Interferon therapy in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis of the comparative trials
    Oliver, Brant J.
    Kohli, Erol
    Kasper, Lloyd H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 302 (1-2) : 96 - 105
  • [28] Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis
    York, Elizabeth N.
    Thrippleton, Michael J.
    Meijboom, Rozanna
    Hunt, David P. J.
    Waldman, Adam D.
    BRAIN COMMUNICATIONS, 2022, 4 (02)
  • [29] Disease modifying therapies in relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Liu, Zhuoyi
    Liao, Qiao
    Wen, Haicheng
    Zhang, Yihao
    AUTOIMMUNITY REVIEWS, 2021, 20 (06)
  • [30] Cognitive Performance in Relapsing-Remitting Multiple Sclerosis: At Risk or Impaired?
    Altieri, Marta
    Fratino, Mariangela
    Maestrini, Ilaria
    Dionisi, Claudia
    Annecca, Rosanna
    Vicenzini, Edoardo
    Di Piero, Vittorio
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2021, 49 (06) : 539 - 543